Cargando…
Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channel...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978386/ https://www.ncbi.nlm.nih.gov/pubmed/31974380 http://dx.doi.org/10.1038/s41467-020-14324-x |
_version_ | 1783490688374013952 |
---|---|
author | Yang, Yongfei Luo, Meiying Zhang, Kexin Zhang, Jun Gao, Tongtong Connell, Douglas O’ Yao, Fengping Mu, Changwen Cai, Bingyu Shang, Yuxue Chen, Wei |
author_facet | Yang, Yongfei Luo, Meiying Zhang, Kexin Zhang, Jun Gao, Tongtong Connell, Douglas O’ Yao, Fengping Mu, Changwen Cai, Bingyu Shang, Yuxue Chen, Wei |
author_sort | Yang, Yongfei |
collection | PubMed |
description | Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channels. Here, the authors show that Nedd4 is induced following erastin treatment, which leads to the ubiquitination and subsequent degradation of the channels. Depletion of Nedd4 limits the protein degradation of VDAC2/3, which increases the sensitivity of cancer cells to erastin. By understanding the molecular mechanism of erastin-induced cellular resistance, we can discover how cells adapt to new molecules to maintain homeostasis. Furthermore, erastin-induced resistance mediated by FOXM1-Nedd4-VDAC2/3 negative feedback loop provides an initial framework for creating avenues to overcome the drug resistance of ferroptosis activators. |
format | Online Article Text |
id | pubmed-6978386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69783862020-01-27 Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma Yang, Yongfei Luo, Meiying Zhang, Kexin Zhang, Jun Gao, Tongtong Connell, Douglas O’ Yao, Fengping Mu, Changwen Cai, Bingyu Shang, Yuxue Chen, Wei Nat Commun Article Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channels. Here, the authors show that Nedd4 is induced following erastin treatment, which leads to the ubiquitination and subsequent degradation of the channels. Depletion of Nedd4 limits the protein degradation of VDAC2/3, which increases the sensitivity of cancer cells to erastin. By understanding the molecular mechanism of erastin-induced cellular resistance, we can discover how cells adapt to new molecules to maintain homeostasis. Furthermore, erastin-induced resistance mediated by FOXM1-Nedd4-VDAC2/3 negative feedback loop provides an initial framework for creating avenues to overcome the drug resistance of ferroptosis activators. Nature Publishing Group UK 2020-01-23 /pmc/articles/PMC6978386/ /pubmed/31974380 http://dx.doi.org/10.1038/s41467-020-14324-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Yang, Yongfei Luo, Meiying Zhang, Kexin Zhang, Jun Gao, Tongtong Connell, Douglas O’ Yao, Fengping Mu, Changwen Cai, Bingyu Shang, Yuxue Chen, Wei Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma |
title | Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma |
title_full | Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma |
title_fullStr | Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma |
title_full_unstemmed | Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma |
title_short | Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma |
title_sort | nedd4 ubiquitylates vdac2/3 to suppress erastin-induced ferroptosis in melanoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978386/ https://www.ncbi.nlm.nih.gov/pubmed/31974380 http://dx.doi.org/10.1038/s41467-020-14324-x |
work_keys_str_mv | AT yangyongfei nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT luomeiying nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT zhangkexin nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT zhangjun nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT gaotongtong nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT connelldouglaso nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT yaofengping nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT muchangwen nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT caibingyu nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT shangyuxue nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma AT chenwei nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma |